There are no verifiable news results provided from the last 24 hours, so I cannot responsibly identify a real-time biotechnology catalyst or write a strictly source-grounded market analysis article about current FDA decisions, cancer trial data, or biotech merger activity.

Because the prompt requires only real, verifiable news from the last 24 hours, the correct output is to avoid invention and flag the data gap rather than fabricate a market-moving development. If you provide fresh headlines, press releases, or search results, I can turn them into a full institutional-style biotech article immediately.